You're contacting media contact of this press release

Title: eDrugstore.com Expands Offerings With Olympus ED3 and New Compound Medications

United States, 29th Jan 2025 - The company is also expanding its portfolio to include additional compound treatments, underscoring its commitment to providing tailored solutions for men’s health.Innovative Approach to Sexual HealthOlympus ED3 features three active ingredients intended to address multiple aspects of sexual health:Tadalafil (20 mg): A generic form of Cialis commonly prescribed to improve erectile function.PT141 (1 mg): Also known as Bremelanotide, a compound under study for its potential effects on sexual desire.Oxytocin (1 IU): Often called the "cuddle hormone," oxytocin is associated with emotional connection and sexual satisfaction.This combination is designed to address challenges such as erectile function, libido, orgasm intensity, and confidence in performance. Patients are encouraged to consult healthcare professionals for personalized guidance, as individual results may vary.Expanded Compound Medication OfferingsIn addition to Olympus ED3, eDrugstore has introduced other compound medication packages targeting specific health concerns:ED Plus DHEA Trial Package: Combines erectile dysfunction treatments with DHEA, a hormone supplement, to support overall health.Hair Trial Package: Offers therapies for managing hair loss.PE Trial Package: Provides options for addressing premature ejaculation.These additions aim to enhance accessibility to personalized healthcare options.A Leader in Telehealth ServicesSince its founding in 1998, eDrugstore has served over 500,000 customers, processing more than 2 million orders in partnership with Secure Medical. In 2019, the company was included on the Inc. 5000 list for its growth and achievements in the industry. More recently, it was recognized as the "Best Digital Pharmacy and Telehealth Platform" in 2024.Enhance...

This press release is issued by King Newswire